Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Relief Therapeutics seeks U.S. emergency approval for drug against COVID-19
ZURICH (Reuters) - Relief Therapeutics said on Wednesday it and U.
Permira buys German specialty pharma group Neuraxpharm
FRANKFURT (Reuters) - Buyout group Permira has agreed to buy German pharma group Neuraxpharm, seeking to gain from an expected rise in demand for the company’s antidepressants, painkillers a...
Once-a-week insulin for type 2 diabetes shows promise in early trial
Type 2 diabetes can be tough to control without medication.
New drug candidate found for hand, foot and mouth disease. Targeting RNA with small molecules could pave the way for new antivirals
DURHAM, N.
Evergreen Theragnostics Breaks Ground on Radiopharmaceutical Factory
Evergreen Theragnostics, located in Jersey City, New Jersey, broke ground for its new manufacturing plant in Springfield, New Jersey.
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
Shares of Denmark-based Genmab A/S fell more than 13% in premarket trading after the company announced late Tuesday that it was squaring off with Janssen in a legal battle over royalties from its ...
FDA Plans New, More Stringent Guidance for COVID-19 Vaccine EUA
Concerns continue to rise over the White House strong-arming the U.
Another One Down: AC Immune and Genentech's Tau Drug Fails Alzheimer's Trial
AC Immune, based in Lausanne, Switzerland, and Genentech, a U.
Roche acquires Irish biotech firm Inflazome
Swiss pharma company Roche is set to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m).
AstraZeneca says Tagrisso shown to slow lung cancer spreading to brain
FRANKFURT (Reuters) - AstraZeneca’s top-selling drug Tagrisso has been shown to slow the spread of a certain type of lung cancer to the brain when diagnosed at an early stage, the British dr...
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2020
Seven new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its September 2020 meeting.
Exclusive: EU in early talks with Italy's ReiThera over potential vaccine supply deal - source
MILAN/BERLIN (Reuters) - Italian biotech ReiThera is in early talks with the European Union about supplying the bloc with its potential COVID-19 vaccine, a source close to the company said, th...
20
21
22
23
24
25
26
27
28
